In This Section

AACR Virtual Patient Advocate Forum

revolution in cancer clinical trials

Tuesday, November 29, 2022


Register for on demand viewing

Clinical trials in oncology are increasing in complexity due to enrollment challenges, protocol deviations, and a staggering amount of data that are increasing costs and adding months to their timelines.  Innovative trial designs may help address some of these challenges. This Forum will review the standard features of the traditional or gold-standard randomized clinical trials and discuss innovative trial designs that are changing the way new treatments are developed for patients with cancer.


Anna D. Barker, PhD, FAACR, Ellison Institute for Transformative Medicine


Margaret Foti, PhD, MD (hc), American Association for Cancer Research

Jane Perlmutter, PhD, MBA, Gemini Group

Douglas Yee, MD, University of Minnesota School of Medicine

Roy S. Herbst, MD, PhD, Yale School of Medicine

Louis M. Weiner, MD, Georgetown Lombardi Comprehensive Cancer Center

Program Agenda Speaker Bios

AACR Patient Advocate Forums

The AACR is committed to providing educational programming to patients with cancer and patient advocacy communities to support their collective mission to find cures for all cancers. AACR Patient Advocate Forums invite leaders from patient advocacy, academia, industry, and healthcare communities to discuss pressing topics and the latest discoveries in cancer research. These virtual forums are provided quarterly at no cost to attendees and open to the public. 

Special thanks to our supporters